Log in to your Inderes Free account to see all free content on this page.

Arcoma

7.12 SEK

-1.93 %

Less than 1K followers

ARCOMA

First North Stockholm

Medical Equipment & Services

Health Care

Overview

Financials & Estimates

Ownership

Investor consensus

-1.93 %

-6.56 %

-20.89 %

-26.75 %

-33.77 %

-35.27 %

-7.53 %

-65.77 %

-46.54 %

Arcoma operates in the medical technology sector. The company is a developer and supplier of integrated digital X-ray systems. The company's products offer digital imaging technology combined with technically advanced mobile positioning systems. The products are sold through resellers and to a large proportion of OEM customers. Operations are found on a global level with sales primarily concentrated in Europe, Asia and North America. The head office is located in Växjö.

Market cap

101.88M SEK

Turnover

49.08K SEK

Revenue

EBIT %

P/E

Dividend yield-%

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar

12.2.

2026

Annual report '25

All

Press releases

ShowingAll content types

Press release10/24/2025, 6:02 AM

DNB Carnegie Access: Arcoma: Europe muted, business mix supports margins – Q3 review

Press release10/13/2025, 4:52 PM

DNB Carnegie Access: Arcoma: Sequential improvements but US uncertainty – Q3 preview

Press release8/25/2025, 8:10 AM

DNB Carnegie Access: Arcoma: Intervju - Intervju efter Q2 2025

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Press release8/22/2025, 6:00 AM

DNB Carnegie Access: Arcoma: US remains muted, easier comparisons in H2 – Q2 review

Press release7/8/2025, 1:02 PM

DNB Carnegie Access: Arcoma: Directed share issue, US to remain muted – Q2 preview

Regulatory press release6/24/2025, 5:15 PM

Arcoma AB successfully completes directed share issue of SEK 11.0 million (~ EUR 1 million) (MAR)

Press release4/29/2025, 2:39 PM

Carnegie Access: Arcoma: Solid gross margin, North America revenue declines – Q1 review

Press release2/17/2025, 2:20 PM

Carnegie Access: Arcoma: Intervju - Avslutar 2024 med starka marginaler (rapportintervju Q4)

Press release2/14/2025, 7:48 AM

Carnegie Access: Arcoma: Margins expand, but Europe remains under pressure – Q4 review

Regulatory press release6/12/2023, 11:00 AM

Arcoma signs distribution agreement with Canon Korea Inc.

Regulatory press release5/3/2023, 8:20 PM

Arcoma AB has received certification according to MDR (MAR)

Regulatory press release4/26/2023, 8:45 AM

Arcoma receives order of 10 systems to Thailand

Regulatory press release9/26/2022, 11:00 AM

Arcoma wins tender of 10 million SEK to Czech Republic (MAR)

Regulatory press release8/24/2022, 8:00 AM

Arcoma receives order of 8 systems to Thailand (MAR)

Regulatory press release7/7/2022, 11:00 AM

Arcoma Precision i5 approved for sales in Singapore

Regulatory press release6/27/2022, 11:00 AM

Arcoma wins important procurement in Finland. (MAR)

Regulatory press release11/18/2021, 3:20 PM

Valberedning utsedd inför årsstämma 2022 i Arcoma AB

Regulatory press release12/1/2020, 9:30 AM

Arcoma launches new X-ray system OMNERA 500A on the US market

Regulatory press release8/20/2020, 8:30 AM

Delårsrapport Q2 2020: Stabil försäljning trots Covid-19. Stark lönsamhetsförbättring under första halvåret.

Regulatory press release5/20/2020, 3:15 PM

Kommuniké från årsstämma i Arcoma AB (publ)

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.